We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Foster
FSTR
$421M
| $481K | 0.01% |
35,873
-7,718
| -18% | -$107K |
|
|
HOUS
802
DELISTED
Anywhere Real Estate
HOUS
| $479K | 0.01% |
+50,792
| New | +$488K |
|
803
BlueLinx
BXC
$430M
| $475K | ﹤0.01% |
+22,081
| New | +$356K |
|
804
Lifecore Biomedical
LFCR
$162M
| $470K | ﹤0.01% |
+48,332
| New | +$460K |
|
805
Shore Bancshares
SHBI
$820M
| $469K | ﹤0.01% |
42,744
-5,458
| -11% | -$54.6K |
|
806
AeroVironment
AVAV
$7.19B
| $468K | ﹤0.01% |
7,796
-6,299
| -45% | -$468K |
|
807
MacroGenics
MGNX
$233M
| $466K | ﹤0.01% |
18,484
-192,152
| -91% | -$5.25M |
|
808
Entravision Communication
EVC
$1.02B
| $465K | ﹤0.01% |
305,675
+277,360
| +980% | +$398K |
|
809
Radiant Logistics
RLGT
$400M
| $461K | ﹤0.01% |
89,762
-54,076
| -38% | -$261K |
|
|
CAMP
810
DELISTED
CalAmp Corp.
CAMP
| $460K | ﹤0.01% |
2,783
-1,824
| -40% | -$342K |
|
|
FRTA
811
DELISTED
Forterra, Inc
FRTA
| $459K | ﹤0.01% |
+38,868
| New | +$517K |
|
|
ACOR
812
DELISTED
Acorda Therapeutics
ACOR
| $456K | ﹤0.01% |
7,377
+6,213
| +534% | +$468K |
|
813
Outfront Media
OUT
$5.75B
| $451K | ﹤0.01% |
31,464
+9,881
| +46% | +$148K |
|
814
Ciena
CIEN
$46.8B
| $447K | ﹤0.01% |
+11,259
| New | +$592K |
|
|
NSTG
815
DELISTED
NanoString Technologies, Inc.
NSTG
| $447K | ﹤0.01% |
10,000
| – | – |
|
816
MillerKnoll
MLKN
$1.56B
| $445K | ﹤0.01% |
+14,745
| New | +$365K |
|
817
Matthews International
MATW
$887M
| $441K | ﹤0.01% |
+19,731
| New | +$423K |
|
|
CYPH
818
Cypherpunk Technologies Inc
CYPH
$64M
| $440K | ﹤0.01% |
+22,238
| New | +$429K |
|
|
HONE
819
DELISTED
HarborOne Bancorp
HONE
| $439K | ﹤0.01% |
54,452
-2,553
| -4% | -$21.8K |
|
820
CNX Resources
CNX
$4.91B
| $438K | ﹤0.01% |
46,427
+29,082
| +168% | +$297K |
|
821
Inseego
INSG
$104M
| $438K | ﹤0.01% |
4,240
| – | – |
|
|
OTIC
822
DELISTED
Otonomy, Inc.
OTIC
| $436K | ﹤0.01% |
107,654
+49,829
| +86% | +$188K |
|
823
Bridgewater Bancshares
BWB
$580M
| $435K | ﹤0.01% |
45,887
-14,044
| -23% | -$134K |
|
|
KALV
824
DELISTED
KalVista Pharmaceuticals
KALV
| $435K | ﹤0.01% |
34,562
+18,434
| +114% | +$230K |
|
|
AD
825
Array Digital Infrastructure
AD
$3.04B
| $435K | ﹤0.01% |
14,728
-4,173
| -22% | -$137K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.